MENU

BDTX Black Diamond Therapeutics Forecast, Technical & Fundamental Analysis

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer... Show more

BDTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
BDTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BDTX is expected to report earnings to fall 82.35% to -2 cents per share on November 05

Black Diamond Therapeutics BDTX Stock Earnings Reports
Q3'26
Est.
$-0.03
Q2'26
Beat
by $0.03
Q1'26
Beat
by $0.03
Q4'25
Missed
by $0.10
Q3'25
Beat
by $0.08
The last earnings report on August 05 showed earnings per share of -17 cents, beating the estimate of -19 cents. With 413.97K shares outstanding, the current market capitalization sits at 119.50M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MMID27.320.27
+0.98%
MFS Active Mid Cap ETF (MMID)
JPHY48.790.05
+0.10%
JPMorgan Active High Yield ETF (JPHY)
SAUG27.09N/A
+0.01%
FT Vest U.S. Small Cap Moderate Buffer ETF - August (SAUG)
ABOT45.50N/A
N/A
Abacus FCF Innovation Leaders ETF (ABOT)
AVUQ65.96-1.56
-2.31%
Avantis U.S. Quality ETF Shs Avantis US Growth Equity ETF (AVUQ)

BDTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with NGEN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then NGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
N/A
NGEN - BDTX
47%
Loosely correlated
-5.33%
MLTX - BDTX
42%
Loosely correlated
+15.87%
REPL - BDTX
39%
Loosely correlated
+2.30%
NAMS - BDTX
38%
Loosely correlated
+0.42%
MLYS - BDTX
36%
Loosely correlated
+1.75%
More
A.I. Advisor
published General Information

General Information

a biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms.

Industry Biotechnology

Industry
N/A
Address
245 First Street
Phone
+1 617 252-0848
Employees
21
Web
https://www.blackdiamondtherapeutics.com
Black Diamond Therapeutics (BDTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com